samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > putting function first in proteomics
PUBLICATIONS
European Biopharmaceutical Review

Putting Function First in Proteomics

The last few years have seen an enormous revival in protein science under the relatively new name of 'proteomics'. The term proteome was coined by Marc Wilkins in 1994, and is used to describe the entire protein complement of the genome. This can be further defined as the protein complement at any point in time - underlining the fact that proteins are complex, dynamic systems constantly changing in number and structure in response to physiological and environmental stimuli. Unlike traditional protein biochemistry, the science of proteomics generally refers to large-scale protein studies involving the high throughput screening and identification of novel proteins. A key aim of proteomics is to uncover the function of novel proteins - so providing possible new targets for drug intervention. Surface plasmon resonance (SPR) technology not only provides a means of isolating novel proteins, but also of uncovering their functional properties.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Stefan Lfs, Vice President and Chief Scientific Officer at Biacore AB

Stefan Lfs holds a PhD and BSc in Organic Chemistry. He has extensive technical and scientific experience in the development and commercialisation of bioanalytical instrumentation at Biacore AB, having worked for the company since 1985. He has been deeply involved in the development of Biacore's sensor chip chemistry and applications. Recently appointed Chief Scientific Officer, he has responsibility for technical development projects, external scientific collaborations and technical aspects on the IPR portfolio. Prior to this role, Dr Lfs was Director of Biacore's Biochemistry and Chemistry department within R&D.
spacer
Stefan Lfs
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables and Leachables testing services at its US Technology Excellence Center

Piombino Dese, Padua Italy and Salt Lake City, USA September 2, 2020: Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed today a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston, MA.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement